CSIMarket
 




Alexion Pharmaceuticals Inc   (ALXN)
Other Ticker:  
 
 



ALXN Price to Sales Ratio (Mar 31 2021) (Dec 31 2020) (Sep 30 2020) (Jun 30 2020) (Mar 31 2020)
Sales Trailing 12 Months I. Quarter IV. Quarter III. Quarter II. Quarter I. Quarter
Price to Sales (TTM) Ratio current            6.49            5.19            4.22            4.33            4.01
Revenue TTM Y / Y Change 18.24 % 21.61 % 23.79 % 23.07 % 22 %
Revenue Y / Y Change 13.27 % 14.99 % 25.78 % 20.05 % 26.69 %
Stock performance to date 17.21 % 33.53 % 9.81 % -1.37 % 6.56 %

Price to sales ratio Comment
Alexion Pharmaceuticals Inc 's current Price to sales ratio has increased due to shareprice growth of 17.21 %, from beginning of I. Quarter and despite Revenue increase of 13.27 %, to Price to Sales of 6.49, from average Price to sales ratio in IV. Quarter of 5.19.

Within Healthcare sector 457 other companies have lower Price to sales ratio.

What is Price to Sales Ratio?
Sales growth by Alexion Pharmaceuticals Inc Segment

Price to sales ratio Company Ranking
Within: No.
Industry #162
Sector #458
S&P 500 #3859






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com